Medicine and Dentistry
Acute Graft Rejection
7%
Allograft
20%
Belatacept
17%
Bilirubin
5%
Biopsy Technique
7%
Body Mass Index
7%
Cholangiocarcinoma
7%
Common Hepatic Artery
6%
COVID-19
14%
Creatinine
7%
Cyclosporine
10%
Disease
5%
End Stage Renal Disease
5%
Graft Failure
13%
Graft Survival
28%
Hazard Ratio
9%
Hepatectomy
12%
Hepatic Portal Vein
6%
Hepatitis B Virus
5%
Hepatitis C
8%
Hepatitis C Virus
8%
Hepatocellular Carcinoma
41%
Human Immunodeficiency Virus
22%
Immunosuppressive Treatment
25%
Infection
8%
Intestinal Transplantation
12%
Ischemia
7%
Kidney Graft
33%
Kidney Transplantation
29%
Liver Cirrhosis
7%
Liver Disease
8%
Liver Graft
46%
Liver Transplantation
99%
Living Donors
32%
Lymphocyte
5%
Machine Perfusion
5%
Milan Criteria
8%
Neoplasm
19%
Nephrectomy
15%
Odds Ratio
6%
Organ Transplantation
8%
Overall Survival
7%
Pediatrics
16%
Rapamycin
6%
Recurrent Disease
12%
Renal Protection
5%
Surgery
13%
Survival Rate
8%
Tacrolimus
6%
Transplantation
55%
Keyphrases
African American
7%
AIDS/HIV
9%
Belatacept
19%
Confidence Interval
10%
COVID-19
12%
Cyclosporine
12%
Deceased Donor
9%
Donation after Circulatory Death
7%
Donor Kidney
13%
Donor Nephrectomy
13%
Downstaging
7%
Extended Criteria Donor
9%
Graft Failure
8%
Graft Loss
9%
Graft Survival
21%
Hazard Ratio
11%
Hepatitis C
9%
Hepatitis C Virus
12%
Hepatocellular Carcinoma
46%
HIV-positive
8%
Immunosuppression
18%
Intestinal Transplantation
13%
Kidney
11%
Kidney Transplant
13%
Kidney Transplant Recipients
24%
Kidney Transplantation
20%
Liver
29%
Liver Allograft
6%
Liver Transplant Recipients
34%
Liver Transplantation
100%
Living Donation
7%
Living Donor
16%
Living Donor Liver Transplantation
13%
Living Liver Donor
8%
Milan Criteria
10%
Orthotopic Liver Transplantation
13%
Patient Survival
11%
Pediatric Liver Transplant
7%
Post-liver Transplantation
8%
Pretransplant
12%
Resection
9%
Right Lobe
7%
Single Center
8%
Single-center Experience
8%
Tacrolimus
12%
Transplant Recipients
9%
Transplantation
32%
Tumor
11%
Underutilization
6%
United States
14%